World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
91
Citations
31218
World Ranking
1959
National Ranking
717

Alan P. Kozikowski publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Alan P. Kozikowski sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 673 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Alan P. Kozikowski D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Alan P. Kozikowski sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 91 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 1978 - Fellow of Alfred P. Sloan Foundation

Overview

Alan P. Kozikowski is affiliated with StarWise Therapeutics LLC in the United States and has focused their research primarily in Biochemistry, Genetics and Molecular Biology, as well as Medicine.

Their research subfields include:

  • Molecular Biology
  • Oncology
  • Cellular and Molecular Neuroscience
  • Infectious Diseases
  • Surgery

Kozikowski's work largely revolves around several core topics:

  • Histone Deacetylase Inhibitors Research
  • Peptidase Inhibition and Analysis
  • Protein Degradation and Inhibitors
  • Signaling Pathways in Disease
  • Hereditary Neurological Disorders
  • Receptor Mechanisms and Signaling
  • Neuropeptides and Animal Physiology

Their recent publications demonstrate a concentration on histone deacetylase 6 (HDAC6) inhibitors, including structural and functional characterizations and therapeutic applications. Notable papers include:

  • "Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor" (2020) published in ACS Medicinal Chemistry Letters
  • "HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice" (2020) published in Experimental Neurology
  • "Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models" (2020) published in Journal of Medicinal Chemistry
  • "Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors" (2020) published in European Journal of Medicinal Chemistry
  • "Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model" (2021) published in Journal of Medicinal Chemistry

Frequent co-authors collaborating with Kozikowski include:

  • Sida Shen
  • Cyril Bařinka
  • Bryan L. Roth
  • J. Ptáček
  • Maurício T. Tavares

The most common publication venues in which Kozikowski's work appears are:

  • Journal of Medicinal Chemistry
  • OPAL (Open@LaTrobe) (La Trobe University)
  • UNC Libraries
  • ACS Medicinal Chemistry Letters
  • Experimental Neurology

In 1978, Alan P. Kozikowski was recognized as a Fellow of the Alfred P. Sloan Foundation. This award highlights an aspect of their professional recognition within the scientific community.

Best Publications

  • Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A.

    Kyle V. Butler;Jay Kalin;Camille Brochier;Guilio Vistoli

  • THE ISOXAZOLINE ROUTE TO THE MOLECULES OF NATURE

    A. P. Kozikowski

  • Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A.

    Mia L. Raves;Michal Harel;Yuan Ping Pang;Israel Silman

  • A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.

    K. P. Maresca;S. M. Hillier;F. J. Femia;D. Keith

  • Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer

    Steve Y. Cho;Kenneth L. Gage;Ronnie C. Mease;Srinivasan Senthamizhchelvan

  • Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents

    Alan P. Kozikowski;Jiazhong Zhang;Fajun Nan;Pavel A. Petukhov

  • Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer

    Catherine A. Foss;Ronnie C. Mease;Hong Fan;Yuchuan Wang

  • Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.

    Annamaria Lilienkampf;Jialin Mao;Baojie Wan;Yuehong Wang

  • Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)

    Alan P. Kozikowski;Fajun Nan;Paola Conti;Jiazhong Zhang

  • Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)

    Sangeeta R. Banerjee;Catherine A. Foss;Mark Castanares;Ronnie C. Mease

  • N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-l-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer

    Ronnie C. Mease;Crystal L. Dusich;Catherine A. Foss;Hayden T. Ravert

  • Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.

    Edwin F. de Zoeten;Liqing Wang;Kyle Butler;Ulf H. Beier

  • Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6.

    Alan P. Kozikowski;Subhasish Tapadar;Doris N. Luchini;Ki Hwan Kim

  • The amino terminus of tau inhibits kinesin-dependent axonal transport: Implications for filament toxicity

    Nichole E. LaPointe;Gerardo A. Morfini;Gerardo A. Morfini;Gustavo F. Pigino;Gustavo F. Pigino;Irina N. Gaisina

  • Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors - What Some May Have Forgotten or Would Rather Forget?

    Sida Shen;Alan P. Kozikowski

  • 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth.

    Youhong Hu;Lixin Qiao;Shaomeng Wang;Suo-bao Rong

  • Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt.

    Alan P. Kozikowski;Haiying Sun;John Brognard;Phillip A. Dennis

  • Methods for the Stereoselective Cis Cyanohydroxylation and Carboxyhydroxylation of Olefins

    Alan P. Kozikowski;Maciej Adamczyk

  • Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth

    Joel A. Bergman;Karrune Woan;Patricio Perez-Villarroel;Alejandro Villagra

  • Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization†

    Cyril Barinka;Youngjoo Byun;Crystal L. Dusich;Sangeeta R. Banerjee

  • Sazetidine-A, A Novel Ligand That Desensitizes α4β2 Nicotinic Acetylcholine Receptors without Activating Them

    Yingxian Xiao;Hong Fan;John L. Musachio;John L. Musachio;Zhi Liang Wei;Zhi Liang Wei

Frequent Co-Authors

Dawei Ma
Dawei Ma Chinese Academy of Sciences
Judith L. Flippen-Anderson
Judith L. Flippen-Anderson United States Naval Research Laboratory
Peter M. Blumberg
Peter M. Blumberg National Institutes of Health
Bhupendra P. Doctor
Bhupendra P. Doctor Walter Reed Army Institute of Research
Clifford George
Clifford George United States Naval Research Laboratory
Garth Powis
Garth Powis Sanford Burnham Prebys Medical Discovery Institute
Giuseppe Campiani
Giuseppe Campiani University of Siena
Stefan R. Nahorski
Stefan R. Nahorski University of Leicester
Jia Zhou
Jia Zhou The University of Texas Medical Branch at Galveston
Alan I. Faden
Alan I. Faden University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a chemistry degree in the USA opens doors to various specialized career paths, many of which offer solid salary prospects and growing demand. For those interested in healthcare and pharmaceuticals, becoming a pharmacist is a rewarding option. Insights on the pharmacist salary can help students understand the financial potential in this field and the educational requirements involved.

Alternatively, roles like pharmaceutical sales representatives combine scientific knowledge with business skills. Learning about the pharmaceutical sales rep salary provides a clearer picture of what to expect in terms of compensation and career progression.

For students fascinated by forensic applications of chemistry, pursuing an affordable online forensic science degree is an excellent way to enter this niche. Programs focused on forensic science often lead to careers as autopsy technicians or related roles in forensic labs. Understanding the autopsy tech salary and job outlook is key to evaluating this pathway's stability and growth potential.

Each of these career trajectories highlights the importance of targeted education and market awareness. Exploring these resources on pharmacist salary, pharmaceutical sales rep salary, autopsy tech salary, and cheapest online forensic science degree can help guide your decisions about online degree programs and future employment.

Best Scientists Citing Alan P. Kozikowski

Trending Scientists

Recently Published Articles